D-1058-2020 Class II Terminated
FDA drug recall D-1058-2020 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Mar 11, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Presence of dark brown discoloration on edges of tablets The recall status is terminated (terminated Jun 10, 2020). Affected quantity: 89,376 90-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2020
- Initiation Date
- Mar 11, 2020
- Termination Date
- Jun 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89,376 90-count bottles
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90
Reason for recall
CGMP Deviations: Presence of dark brown discoloration on edges of tablets
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1058-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026